Home / health news / Sports Perspectives : declared in Bristol-Myers Squibb Company (BMY) Receives Buy Rating from Jefferies Group LLC
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

Sports Perspectives : declared in Bristol-Myers Squibb Company (BMY) Receives Buy Rating from Jefferies Group LLC

according to Receive News & Ratings for Bristol-Myers Squibb Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bristol-Myers Squibb Company and related companies with MarketBeat.com’s FREE daily email newsletter.
About Bristol-Myers Squibb CompanyBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.
Jefferies Group LLC reiterated their buy rating on shares of Bristol-Myers Squibb Company (NYSE:BMY) in a research report released on Tuesday morning.
COPYRIGHT VIOLATION WARNING: “Bristol-Myers Squibb Company (BMY) Receives Buy Rating from Jefferies Group LLC” was posted by Sports Perspectives and is owned by of Sports Perspectives.
Barclays PLC restated an equal weight rating on shares of Bristol-Myers Squibb Company in a report on Wednesday, October 12th.

As it stated in

SunTrust Banks Brokers Lower Earnings Estimates for Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company Company ProfileBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.
Bristol-Myers Squibb Company (NYSE:BMY) – SunTrust Banks decreased their FY2018 EPS estimates for shares of Bristol-Myers Squibb Company in a report issued on Monday.
COPYRIGHT VIOLATION NOTICE: “SunTrust Banks Brokers Lower Earnings Estimates for Bristol-Myers Squibb Company (BMY)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem.
Bristol-Myers Squibb Company (NYSE:BMY) last issued its quarterly earnings data on Thursday, January 26th.
Bristol-Myers Squibb Company had a net margin of 22.94% and a return on equity of 31.39%.

As it stated in Bristol-Myers Squibb Company Company ProfileBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.
Intrust Bank NA’s holdings in Bristol-Myers Squibb Company were worth $1,145,000 as of its most recent filing with the SEC.
Bank of Montreal Can purchased a new position in Bristol-Myers Squibb Company during the second quarter valued at $154,732,000.
On average, equities research analysts anticipate that Bristol-Myers Squibb Company will post $2.81 earnings per share for the current year.
Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bristol-Myers Squibb Company (NYSE:BMY).

about the details read more from here

This content may collect you by Luaren Colin

To follow all the new news about health

Check Also

picture.jpg

2 missing girls found safe, mother detained according to : KCRA

as informed in Two missing girls were found safe after being taken by their biological …